NY-BR-1 is a differentiation antigen of the mammary gland

Applied Immunohistochemistry and Molecular Morphology

Volumn 15, Issue 1, 2007, Pages 77-83

  Jäger, Dirk ^a   Filonenko, Valeriy ^b   Gout, Ivan ^b,c   Frosina, Denise ^d   Eastlake Wade, Susannah ^d   Castelli, Sandra ^d   Varga, Zsuzsanna ^f   Moch, Holger ^f   Chen, Yao Tseng ^e   Busam, Klaus J ^d   Seil, Inka ^g   Old, Lloyd J ^d   Nissan, Aviram ⁱ   Frei, Claudia ^h   Gure, Ali O ^d   Knuth, Alexander ^h   Jungbluth, Achim A ^d  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

^f Departments of Pathology   (Egypt)

^g INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

^h UNIVERSITY HOSPITAL ZURICH   (Switzerland)

ⁱ HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Breast cancer; Breast differentiation antigen; NY BR 1

Indexed keywords

MESSENGER RNA; MONOCLONAL ANTIBODY; PROTEIN NY BR 1; RECOMBINANT PROTEIN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; BREAST DUCT; BREAST EPITHELIUM; CANCER DIAGNOSIS; CARCINOMA IN SITU; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; EMBRYO; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SWEAT GLAND CARCINOMA; TESTIS; TISSUE SPECIFICITY; TUMOR DIFFERENTIATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, DIFFERENTIATION; ANTIGENS, NEOPLASM; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNIZATION; MAMMARY GLANDS, HUMAN; MICE; MICE, INBRED BALB C; SWEAT GLAND NEOPLASMS;

EID: 34247588785     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/01.pai.0000213111.05108.a0     Document Type: Article

References (28)

1. Jager D, Stockert E, Gure AO, et al. Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library. Cancer Res. 2001;61:2055-2061.
2. Jager D, Unkelbach M, Frei C, et al. Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum. Cancer Immun. 2002;2:5.
3. Chen YT, Stockert E, Chen Y, et al. Identification of the MAGE-1 gene product by monoclonal and polyclonal antibodies. Proc Natl Acad Sci USA. 1994;91:1004-1008.
4. Chen YT, Stockert E, Jungbluth A, et al. Serological analysis of Melan-A[MART-1], a melanocyte-specific protein homogeneously expressed in human melanomas. Proc Natl Acad Sci USA. 1996;93:5915-5919.
5. Jungbluth AA, Stockert E, Chen YT, et al. Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours. Br J Cancer. 2000;83:493-497.
6. Jungbluth AA, Iversen K, Coplan K, et al. T311-an anti-tyrosinase monoclonal antibody for the detection of melanocytic lesions in paraffin embedded tissues. Pathol Res Pract. 2000;196:235-242.
7. Jungbluth AA, Chen YT, Stockert E, et al. Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues. Int J Cancer. 2001;92:856-860.
8. Boon T, Old LJ. Cancer Tumor antigens. Curr Opin Immunol. 1997;9:681-683.
9. Scanlan MJ, Gure AO, Jungbluth AA, et al. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev. 2002;188:22-32.
10. Davis ID, Chen W, Jackson H, et al. Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4[+] and CD8[+] T cell responses in humans. Proc Natl Acad Sci USA. 2004;101:10697-10702.
11. van Baren N, Brasseur F, Godelaine D, et al. Genes encoding tumor-specific antigens are expressed in human myeloma cells. Blood. 1999;94:1156-1164.
12. Jager E, Stockert E, Zidianakis Z, et al. Humoral immune responses of cancer patients against "cancer-testis" antigen NY-ESO-1: correlation with clinical events. Int J Cancer. 1999;84:506-510.
13. Knuth A, Jager D, Jager E. Cancer immunotherapy in clinical oncology. Cancer Chemother Pharmacol. 2000;46:46-51.
14. Jager D, Jager E, Knuth A. Vaccination for malignant melanoma: recent developments. Oncology. 2001;60:1-7.
15. Kleene KC. Patterns, mechanisms, and functions of translation regulation in mammalian spermatogenic cells. Cytogenet Genome Res. 2003;103:217-224.
16. Kleene KC. Sexual selection, genetic conflict, selfish genes, and the atypical patterns of gene expression in spermatogenic cells. Dev Biol. 2005;277:16-26.
17. Dennis JL, Hvidsten TR, Wit EC, et al. Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm. Clin Cancer Res. 2005;11:3766-3772.
18. Hammar SP, Orenstein JM. Metastatic neoplasms of unknown primary origin: an overview. Ultrastruct Pathol. 1992;16:3-5.
19. Kaufmann O, Koch S, Burghardt J, et al. Tyrosinase, melan-A, and KBA62 as markers for the immunohistochemical identification of metastatic amelanotic melanomas on paraffin sections. Mod Pathol. 1998;11:740-746.
20. Jungbluth AA, Busam KJ, Gerald WL, et al. A103: An anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues. Am J Surg Pathol. 1998;22:595-602.
21. Dabbs DJ, Landreneau RJ, Liu Y, et al. Detection of estrogen receptor by immunohistochemistry in pulmonary adenocarcinoma. Ann Thorac Surg. 2002;73:403-405.
22. Dennis JL, Hvidsten TR, Wit EC, et al. Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm. Clin Cancer Res. 2005;11:3766-3772.
23. Busam KJ, Gellis S, Shimamura A, et al. Small cell sweat gland carcinoma in childhood. Am J Surg Pathol. 1998;22:215-220.
24. Kariya Y, Moriya T, Suzuki T, et al. Sex steroid hormone receptors in human skin appendage and its neoplasms. Endocr J. 2005;52:317-325.
25. Bertheau P, Cazals-Hatem D, Meignin V, et al. Variability of immunohistochemical reactivity on stored paraffin slides. J Clin Pathol. 1998;51:370-374.
26. Fergenbaum JH, Garcia-Closas M, Hewitt SM, et al. Loss of antigenicity in stored sections of breast cancer tissue microarrays. Cancer Epidemiol Biomarkers Prev. 2004;13:667-672.
27. Jacobs TW, Prioleau JE, Stillman IE, et al. Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer. J Natl Cancer Inst. 1996;88:1054-1059.
28. Vis AN, Kranse R, Nigg AL, et al. Quantitative analysis of the decay of immunoreactivity in stored prostate needle biopsy sections. Am J Clin Pathol. 2000;113:369-373.